This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Teriflunomide

Read time: 1 mins
Marketing start date: 26 Nov 2024
...
 

Summary of product characteristics


Effective Time

20230927

Version

2

Spl Product Data Elements

Teriflunomide Teriflunomide TERIFLUNOMIDE TERIFLUNOMIDE CELLULOSE, MICROCRYSTALLINE HYPROMELLOSES LACTOSE MONOHYDRATE MAGNESIUM STEARATE POLYETHYLENE GLYCOL, UNSPECIFIED SODIUM STARCH GLYCOLATE TYPE A POTATO STARCH, CORN TITANIUM DIOXIDE WHITE TO OFF WHITE ROUND 1114 Teriflunomide Teriflunomide TERIFLUNOMIDE TERIFLUNOMIDE CELLULOSE, MICROCRYSTALLINE FD&C BLUE NO. 2 HYPROMELLOSES LACTOSE MONOHYDRATE MAGNESIUM STEARATE POLYETHYLENE GLYCOL, UNSPECIFIED SODIUM STARCH GLYCOLATE TYPE A POTATO STARCH, CORN TITANIUM DIOXIDE BLUE TO LIGHT BLUE ROUND 1115

Application Number

ANDA209668

Brand Name

Teriflunomide

Generic Name

Teriflunomide

Product Ndc

70771-1011

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1010-3 Teriflunomide Tablets, 7 mg 30 Tablets Rx only NDC 70771-1011-3 Teriflunomide Tablets, 14 mg 30 Tablets Rx only 7 mg 14 mg

Spl Medguide

SPL MEDGUIDE

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.